Multiomics Market

Multiomics Market Overview

The multiomics market size is projected to grow from USD 3.10 billion in 2025 to USD 12.65 billion by 2035, representing a CAGR of 15.09% during the forecast period till 2035.

To learn more about this report, request a free sample copy

The new research study consists of multiomics market and trends analysis, detailed market forecast analysis, and provide actionable strategic recommendations.

Multiomics refers to an advanced approach in biological research that integrates data from multiple Omics such as genomics, transcriptomics, proteomics, metabolomics and epigenomics to gain a comprehensive understanding of biological systems, diseases, and drug response. With the prevalence of the COVID-19 pandemic, the multiomics market demand had experienced a spike and accelerated the adoption and advancement of multiomics research. Scientists had leveraged multiomics approaches to comprehend the virus, host response, and potential treatments. Thus, the positive impact of COVID-19 on multiomics research has doubled the potential growth of the multiomics technology.

Furthermore, the benefits of single-cell multiomics are an additional key driver that revolutionizes biomedical research by unveiling cellular heterogeneity, providing deeper disease insights, enhancing precision medicine, and offering comprehensive multi-omics integration. Further, the expanding applications of multiomics including cancer research, neurological disorders, infectious diseases, and agriculture & microbiome studies are multiplying the market scope. The role of multiomics in drug discovery is critical as it aids in identifying novel drug targets, improving biomarker discovery, and optimizing drug response & personalizing medicine.

Resulted in, biomedical firms and emerging drug discovery companies are investing in the industry to leverage the technology. For instance, in May 2024, MultiOmic Health raised $6.2 million in a seed funding extension to develop its precision therapeutic platform for metabolic syndrome-related conditions. The funding was led by Hoxton Ventures with support from Ada Ventures. “Lower omics data costs and AI-driven data science are creating new opportunities to advance precision medicine for metabolic syndrome patients,” said Alasdair Thong, co-founder and non-executive director of MultiOmic.

Apart from key drivers, the market faces some data integration challenges in the implementation of the technology which can affect the market growth. Overall, the future trends in integrated omics platforms driven by AI-powered data analysis and cloud-based bioinformatics will likely expand the elevate the market demand by enabling deeper insights into disease mechanisms during this forecast period.

Multiomics Market Share Insights

The multiomics market report presents an in-depth analysis of the various companies that are involved in offering multiomics, across different segments, as defined in the table below:

Multiomics Market : Report Attributes / Market Segmentations

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	Till 2035
Current Market Size	$ 3.10 Billion
Market Size Value by 2035	$ 12.65 Billion
CAGR (Till 2035)	15.09%
Type of Product & Service	Consumables Instruments Products Services Software
Type of Multiomics	Bulk Multiomics Single-Cell Multiomics
Type of Platform	Genomics Integrated Omics Platforms Metabolomics Proteomics Transcriptomics
Type of Application	Cell Biology Immunology Neurology Oncology
Type of End-User	Academic and Research Institutes Pharmaceutical & Biotechnology Companies Others
Geographical Regions	North America US Canada Mexico Other North American countries Europe Austria Belgium Denmark France Germany Ireland Italy Netherlands Norway Russia Spain Sweden Switzerland UK Other European countries Asia China India Japan Singapore South Korea Other Asian countries Latin America Brazil Chile Colombia Venezuela Other Latin American countries Middle East and North Africa Egypt Iran Iraq Israel Kuwait Saudi Arabia UAE Other MENA countries Rest of the World Australia New Zealand Other countries
Leading Market Players	Agilent Technologies BD BGI Genomics Bruker Danaher Illumina PerkinElmer QIAGEN Shimadzu Thermo Fisher Scientific
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Competitive Landscape Company Competitive Analysis Patent Analysis Funding Analysis Recent Developments Market Forecast and Opportunity Analysis

Multiomics Market Segmentation

Market Share by Type of Product & Service

Based on the type of product & service, the product segment dominates the segment with (~49%) of the current market share. The increasing number of product launches and advanced technologies such as next-generation sequencing, mass spectrometry, and single-cell analysis platforms are driving the market growth. While the service segment is expected to grow at a higher (19.34%) CAGR over this projection timeframe. The key factor of this growth can be ascribed to the growing complexity of multiomics data which has uplifted the demand for AI-driven tools, cloud-based platforms, and integrated data analysis software.

Market Share by Type of Multiomics

This segment of the market is fragmented into bulk multiomics and single-cell multiomics. According to this multiomics market forecast report, bulk multiomics is a leading segment and is projected to hold (~62%) of the market share by 2035. Ongoing innovations in bulk multiomics applications are a key factor in bolstering the segment’s growth. Particularly, the widespread applications in disease research and clinical & translational research are raising the demand for multiomics technology.

Furthermore, the single-cell multiomics segment is poised to register an excellent (17.11%) growth rate throughout this forecast period. Single-cell multiomics provides high-resolution biological insights at the individual cell level. Also, innovations in single-cell multiomics technologies have improved accuracy in studying cancer, neurology, and immunology, thereby, fostering market expansion.

Market Share by Type of Platform

The distribution of the market for multiomics is categorized into various platforms, including genomics, integrated omics platforms, metabolomics, proteomics, and transcriptomics. As per multiomics market research, genomics has been a leading segment by occupying (~43%) of the current market share. Genomics, specifically, the next-generation sequencing platforms’ ability to generate comprehensive and high-throughput data for varus genomic applications from whole-genome sequencing to exome sequencing contribute to this growth due to their versatility and cost reduction.

Market Share by Type of Application

On the basis of the type of applications, the oncology application is expected to continue to lead the segment (~44%) of the market share till 2035. The ability to analyze tumor heterogeneity at the molecular level by using genomics, proteomics, and metabolomics is advancing the field of oncology. Multiomics enables the identification of tumor biomarkers for early cancer detection and personalized treatment plans. Besides, multiomics provides insights into drug resistance, immune response, and tumor progression which help optimize cancer therapies. As a result, the oncology segment is also expected to continue to expand at a noteworthy CAGR of (18.33%) during this forecast period.

Market Share by Type of End User

The segment of the multiomics underscores a diverse range of end users wherein academic & research institutions are the dominating end users and are anticipated to acquire (~47%) of the market share till the forecast period. These organizations are at the forefront of basic research, using multiomics to comprehend disease mechanisms, genetic variation, and biological pathways. Also, for research institutions, the technology is an essential tool for studying cellular processes and pathophysiology, escalating the market demand. Moreover, biotechnology firms and pharmaceutical companies are fortifying the market growth and is likely to experience a faster (18.5%) CAGR in the upcoming decade due to biomarker discovery through multiomics data that aid in identifying novel drug targets and boost the drug development process.

Market Share by Geographical Regions

This segment highlights the distribution of the Multiomics Market across various geographical regions, such as North America, Europe, Asia, Latin America, the Middle East and North Africa, and the rest of the world. With regard to regional analysis of multiomics adoption, North America is poised to capture the majority (~49%) of the market share till the forecast period.

Moreover, the market is expanding speedily in Asia and is expected to continue to rise at a faster (19.52%) growth rate throughout this projection timeframe. The major contributing factor to this growth is the growing investment and funding for genomics research to advance biochemical science, drug discovery, and precision medicine in prominent countries like China, India, and Japan. For instance, in February 2025, Singleron Biotechnologies teamed up with Bioscreen, an eminent distributor of advanced life science products in India to serve exclusive distributor of Singleron’s state-of-art- single-cell multi-omics solutions across the Indian market.

Multiomics Market Key Insights

The “Multiomics Market, Till-2035: Industry Trends and Global Forecasts” report features an extensive study of the current market landscape, market size and future opportunities within the multiomics market, during the given forecast period. The market report highlights the efforts of several stakeholders involved in this rapidly emerging segment of the service providers industry. Key takeaways of the multiomics market report are briefly discussed below.

Key Drivers of the Multiomics Market

The multiomics market is experiencing exponential growth due to multiple key drivers, however, the ongoing advancements in omics technologies are supplementing the multiomics market growth. Innovations in next-generation sequencing, mass spectrometry, single-cell, and AI-driven bioinformatics are allowing researchers to extract deeper biological insights and improve disease understanding and drug discovery. Thus, the rising demand for advanced sequencing technologies augments market development. Moreover, the ongoing trends in personalized medicine using multiomics boosting the market growth. This is due to its critical role in precision medicine which aids in tailoring treatments based on an individual’s genetic and molecular profile.

Multiomics Market Competitive Landscape

Several global companies including Thermo Fisher, Agilent Technologies, BD, QIAGEN, and others are shaping the competitive landscape of the market. These leading key players in multiomics market influence the market growth with their technological advancements, myriads of offerings, and strong R&D capabilities. Several bioinformatics firms, life science companies and emerging startup companies are focusing on strategic partnerships in multiomic research to provide advanced omics platforms and multiomics solutions which further help them gain a competitive edge in the competitive environment.

Market Challenges in Multiomics Market

Multiomic research entails analyzing multiple biological datasets such as transcriptomics, metabolomics, genomics and proteomics to gain a holistic comprehension of biological systems. Nevertheless, integrating these diverse datasets poses considerable challenges in implementing multiomics technologies due to differences in data structure, format, and interpretation. Therefore, complexity in data integration remains a barrier in multiomics research which can halt the market growth to reach its full potential.

Regional Analysis: North America is Expected to Dominate the Market with the Largest Multiomics Market Share

North America has been at the forefront of the healthcare industry and is expected to dominate the market for multiomics with (~49%) of the market share till 2035. Advanced healthcare & research infrastructure is the key factor behind the region’s dominance. North America has world-class research facilities and high investment in life science studies where leading institutions such as Harvard, MIT, and the National Institute of Health contribute to multiomics research.

Along with this, the top biotech and pharmaceutical companies headquartered in the region drive the market development through their innovation in personalized medicine solutions & genomics. For instance, in March 2024, BioSkryb introduced a next-generation genome and transcriptome core kits to advance single-cell multiomics. This nee ResolveDNA and ResolveOME single-cell kits create sequencing-ready libraries within eight hours.

Leading Multiomics Companies

Examples of key players involved in the market for multiomics (which have also been captured in this market report, arranged in alphabetical order) include Agilent Technologies (US), BD (US), BGI Genomics (China), Bruker (US), Danaher (US), Illumina (US), PerkinElmer (US), QIAGEN (Germany), Shimadzu (Japan), Thermo Fisher Scientific (US). This market report includes an easily searchable excel database of all the companies who have adopted the multiomics market.

Recent Developments in Multiomics Market

• In January 2024, Enhanc3D Genomics introduced a suite of integrated multi-mics solutions to advance and boost the precision of drug discovery. This new offering offers partners a powerful end-to-end solution to support and better decision-making through every stage of the drug discovery and development operation.
• In December 2024, DNAnexus collaborated with Panomics to deliver inclusive multi-omics data management and analysis solutions to biopharma organizations. This offering allows better transcriptomics and proteomics data analysis workflows for biomarker discovery and drug repurposing.
• In September 2024, The Indian Cancer Genome Atlas unveiled India’s first comprehensive cancer multi-omics data portal. The platform is designed to offer open access to clinically correlated data from Indian cancer patients to enhance cancer research treatment for Indian populations.

Multiomics Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain, across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report multiomics market, 2020-2024 (Historical Trends) and till-2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the multiomics market providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall multiomics market including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view on the current state of the multiomics market their likely evolution in the mid-long term.
• A detailed assessment of the multiomics market landscape, based on several relevant parameters, including year of experience, company size, location of headquarters, and ownership structure.
• Elaborate profiles of prominent players engaged in the multiomics market, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, multiomics market portfolio, moat analysis, recent developments, and an informed future outlook.
• A qualitative assessment of the various megatrends ongoing in the multiomics industry, including soaring integration of artificial intelligence and machine learning, advancements in single-cell multiomics, and expansion in precision medicine.
• An analysis highlighting the key unmet needs across the multiomics market, featuring insights generated from real-time data on unmet needs as identified from social media posts, recent publications, industry blogs and the views of key opinion leaders expressed on online platforms.
• An in-depth analysis of various patents that have been filed / granted related to multiomics market and its components, based on various parameters, such as type of patent, patent publication year, patent age and leading players.
• A detailed analysis of recent developments in the multiomics market domain, based on relevant parameters such as year of initiative, type of initiative (partnerships and collaborations, expansions, funding and product launches), geographical distribution and most active players (in terms of number of recent developments).
• Key winning strategies framework that helps in analyzing the level of competition within an industry, by tracing the key market activities including partnership, funding, expansion of leading players
• A qualitative analysis, highlighting the five competitive forces prevalent in multiomics market, including threats for new entrants, bargaining power of suppliers, bargaining power of customers, threats of substitution and rivalry among existing competitors.
• A discussion on affiliated global multiomics market trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall multiomics market.
• A value chain analysis featuring a discussion on various stakeholders involved in the development of the multiomics market, from suppliers to end-users.
• A detailed estimate of the current market size and the future growth potential of the multiomics market over the next decade. Based on multiple parameters we have provided an informed estimate on the market evolution during the forecast period 2025-2035. The report also features the likely distribution of the current and forecasted opportunity within the multiomics market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future market across various types of products & services such as consumables, instruments, products, services, and software.
• Detailed projections of the current and future market across various types of multiomics such as bulk multiomics and single-cell multiomics.
• Detailed projections of the current and future market across various types of platforms such as genomics, integrated omics platforms, metabolomics, proteomics, and transcriptomics.
• Detailed projections of the current and future market across various types of applications such as cell biology, immunology, neurology, and oncology.
• Detailed projections of the current and future market across various types of end users such as academic and research institutes, pharmaceutical & biotechnology companies, and others.
• Detailed projections of the current and future multiomics market across various geographical regions, such as North America (US, Canada, Mexico and other North American countries), Europe (Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Norway, Russia, Spain, Sweden, Switzerland, UK and other European countries), Asia (China, India, Japan, Singapore, South Korea and other Asian countries), Middle East and North Africa (Egypt, Iran, Iraq, Israel, Kuwait, Saudi Arabia, UAE and other MENA countries), Latin America (Brazil, Chile, Colombia, Venezuela and other Latin American countries) and rest of the world (Australia, New Zealand and other countries).

Author: Ronit Sharma and Neha Kashyap